Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999. by Platonov, A. E. et al.
128 Emerging Infectious Diseases Vol. 7, No. 1, January–February 2001
Dispatches
West Nile (WN) virus is a member of the
Japanese encephalitis (JE) antigenic complex of
the genus Flavivirus, family Flaviviridae.
Mosquito-borne WN virus fever is endemic in
Africa, the Middle East, and Southwest Asia. The
antigenically and genetically related Kunjin
virus is a WN virus counterpart in Australia and
Southeast Asia and has recently been taxonomi-
cally classified as a subtype of WN virus. Until
recently, WN virus infection in humans was
considered a relatively mild, influenzalike
disease with full recovery, although occasionally
(<15% of cases) acute aseptic meningitis or
encephalitis occurred  (1). No large outbreak of
WN virus fever was reported in Europe until
August and September 1996, when more than
500 clinical cases were observed in Romania
(Bucharest region), with  high rates of neurologic
disorders and death (up to 10%) (2). WN virus had
never been detected in the Western Hemisphere
until August 1999, when an outbreak of human
WN encephalitis in New York City (56 confirmed
cases, 7 deaths) coincided with unusual deaths in
crows and exotic birds (3-5).
The Study
In August and September 1999, an outbreak
of acute viral infection consistent with arboviral
infection occurred in the Volgograd Region,
Russia. Epidemiologic and clinical data were
collected and analyzed in the Center of Sanitary
and Epidemic Control for the Volgograd Region
in collaboration with the Commission of the
Russian Ministry of Public Health. From July 25
to October 1, 826 patients were admitted to area
hospitals with the clinical diagnosis of acute
aseptic meningoencephalitis (code A86, ICD-10;
84 patients), acute aseptic meningitis (code
A87.9; 308 patients), or acute viral infection with
fever (code B34.9; 347 patients). Serum samples
from 318 patients were tested for WN  virus
antibody by immunoglobulin (Ig)M-capture
enzyme-linked immunosorbent assay (ELISA)
and indirect IgG ELISA (2,6); 183 (58%) samples
demonstrated a level of anti-WN virus IgM
indicative of acute infection. This proportion was
approximately the same in patients with aseptic
meningoencephalitis, aseptic meningitis, and
acute fever. These 183 cases were considered
serologically confirmed WN virus cases; all 826
cases were considered clinically compatible WN
virus cases. The total number of suspected overt
human WN virus cases was estimated to be 480.
Outbreak of West Nile Virus Infection,
Volgograd Region, Russia, 1999
Alexander E. Platonov,* German A. Shipulin,* Olga Yu. Shipulina,*
Elena N. Tyutyunnik,† Tatyana I. Frolochkina,‡
Robert S. Lanciotti,§ Svetlana Yazyshina,¶ Olga V. Platonova,
* Igor L. Obukhov,¶ Alexander N. Zhukov,**
Yury Ya. Vengerov,† and Valenin I. Pokrovskii*
*Central Institute of Epidemiology, Moscow, Russia; †Moscow State
University for Medicine and Dentistry, Russia; ‡Ministry of Public Health,
Moscow, Russia; §Centers for Disease Control and Prevention,
Fort Collins, Colorado, USA; ¶Russian State Institute for Control of
Veterinary Products, Moscow, Russia; **Center of Sanitary and
Epidemic Control for Volgograd Region, Volgograd, Russia
Address for correspondence:  A.E. Platonov, Central Institute
of Epidemiology, Novogireevskaya Str. 3A, Moscow 111123,
Russia; Fax: 7-095-305-5423; e-mail: plt@online.ru.
From July 25 to October 1, 1999, 826 patients were admitted to Volgograd Region,
Russia, hospitals with acute aseptic meningoencephalitis, meningitis, or fever
consistent with arboviral infection. Of 84 cases of meningoencephalitis, 40 were fatal.
Fourteen brain specimens were positive in reverse transcriptase-polymerase chain
reaction assays, confirming the presence of West Nile/Kunjin virus.129 Vol. 7, No. 1, January–February 2001 Emerging Infectious Diseases
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Volgograd City (population 1 million) is
located on the west bank of the Great Volga River
(latitude 48°N, longitude 44°E) in the Russian
steppe; Volzskii City (population 300,000) is on
the opposite bank. Approximately 65% and 30%
of WN virus cases were from Volgograd and
Volzskii, respectively; the rest occurred in the
rural region around Volgograd, near the Volga
River or its tributaries. The male:female
infection ratio was 1:1. The incidence of infection
was age specific; more than 50% of patients were
>50 years of age and less than 15% were <15
years. The epidemic peaked between August 21
and August 25, waning with the onset of cooler
temperatures in late September. Figures were
similar for serologically confirmed and clinically
probable WN virus cases.
The clinical characteristics of the Volgograd
WN virus epidemic differed somewhat from those
of previous outbreaks (1). In Volgograd, the
disease was generally more severe, with a higher
than normal case-fatality rate. The central
nervous system was usually involved, and acute
aseptic meningitis or encephalitis was frequently
observed. Rash and conjunctivitis were rarely
observed. Abdominal pain, diarrhea, respiratory
symptoms, and lymphadenopathy were rare or
absent. As in other WN virus epidemics, clinical
features included abrupt onset of disease,
asthenia, high fever (up to 39°C-40°C), headache,
and vomiting.
Of the 84 cases of acute aseptic meningoen-
cephalitis, 40 were fatal (7). Autopsies of
laboratory-confirmed WN meningoencephalitis
cases revealed perivascular hemorrhages, ecta-
sis of ventriculi of the brain, foci of encephaloma-
lacia, dislocation of the brain trunk (30% of
cases), and hydropericarditis with flabbiness of
the cardiac muscle. Microscopy findings included
signs of focal encephalitis and vasculitis,
lymphocytic perivascular inflammatory infiltra-
tion, profound degenerative and necrobiotic
changes of ganglion cells in the cerebral cortex,
and signs of brain edema, as well as parenchymal
myocarditis (stromal edema, degeneration of
myocytes, foci of myolysis, and fragmentation of
myofibrils). Thirty (75%) of the patients who died
were >60 years of age.
We have developed reverse transcriptase-
polymerase chain reaction (RT-PCR) assays
specific for WN/Kunjin genome and a consensus
assay for the detection of all flavivirus genomes
(5,8, 9). Two pairs of oligonucleotide primers
(WN11/WN2, WN1/WN2) were designed to
hybridize to a relatively conserved region within
the envelope (E) gene of WN/Kunjin viruses. The
expected amplification product was 222 base
pairs long (WN1, 5'- AGG, GGC, CAC, CCA, GGC,
TGG, AAG, ATT, CA- 3'; WN11,   5'-TGG, GGC,
CAC, TCA, GGC, AGG, GAG, ATT, CA-3'; WN2,
5'-CAC, GTG, GTG, CTT, CCA, GCA, CTG, CTC,
CA-3'). Another pair of primers, FLV1/FLV2, was
designed to hybridize to conserved regions within
the RNA replicase (NS5) gene of a wide variety of
flaviviruses, amplifying nearly a 220-bp frag-
ment (FLV1, 5'-GGI, AGC, AGI, GCC, ATI, TGG,
T(A/T)C, ATG, TGG - 3'; FLV-2, 5'-C(G/T)I, GTG,
TCC, CAI, CCI, GCI, GTG, TCA, TC-3').
Brain tissue samples taken at autopsy from
14 patients with  meningoencephalitis were
subjected to RT-PCR with primer pairs WN11/
WN2, WN1/WN2, and FLV1/FLV2. The samples
and corresponding viral RNA/cDNA prepara-
tions are designated below as Volgograd-1999-1,
Volgograd-1999-2, and the like. Two WN virus
strains isolated in 1967-1970 in the Republic of
Azerbaijan (former Soviet Union) and the
prototype JE strain isolated in Tokyo were used
as control templates in the RT-PCR assay. All 14
brain samples were strongly positive in the RT-
PCR assays with WN11/WN2, WN1/WN2, and
FLV1/FLV2, confirming the presence of WN/
Kunjin sequences. The WN-Azerbaijan-1967 and
WN-Azerbaijan-1970 control RNA preparations
were positive only with WN11/WN2 and FLV1/
FLV2 primer pairs, indicating that some
differences in the corresponding region of the E
gene from the old and new “Russian” WN virus
strains were likely. As expected, the JE-Tokyo-
1935 RNA preparation was negative in the WN-
specific RT-PCR assay, but positive with FLV1/
FLV2 primers.
The amplification products obtained from the
E and NS5 genes from seven patients (#1, 3, 7, 11,
12, 13, 14) and from the reference WN-Azerbaijan-
1967 and WN-Azerbaijan-1970 strains were
subjected to DNA sequencing. The sequences
obtained from the Volgograd patients were
identical, suggesting infection with a single WN
virus strain.
The E sequences of the Volgograd and
Azerbaijan WN viruses were aligned with each
other and with 38 other WN/Kunjin strains, by
using CLUSTAL W alignment software. The NS5
sequences of the Volgograd and Azerbaijan WN
viruses were aligned with 16 other flavivirus130 Emerging Infectious Diseases Vol. 7, No. 1, January–February 2001
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strains by CLUSTAL W. The high level of
sequence similarity confirmed the WN virus
source of the Volgograd cases (Table). Phyloge-
netic trees of WN/Kunjin viruses and all
flaviviruses derived from E and NS5 gene
sequences (5,8-10) have been previously de-
scribed. We used smaller gene fragments, 165
bases of E gene and 147 bases of NS5 gene;
however, the deduced phylogenetic trees were
practically the same. Therefore, we limited the
analysis to the most similar strains, including the
epidemiologically important WN-New-York-1999
and WN-Romania-1996 strains, and some
representatives of other taxonomic subdivisions.
For comparison, the designation of strains
coincides with the designation in publications
where the additional details of strain history are
given (5,10).
The Volgograd and old Azerbaijan WN virus
strains clearly belonged to “lineage 1” of WN
virus isolates (5,9-10). Within lineage 1, the
Volgograd patient strains were most closely
related to the current Kenya and Senegal strains
and the Romanian mosquito isolate (the identical
E gene fragment of 165 nucleotides [nt]). The
Azerbaijan isolates were more closely related to
Table. Percentage identity of nucleotide sequence for E and NS5 gene fragments among West Nile/Kunjin viruses
     WN-
  WN-  New York-
  Kenya-   1999F
1998 and     and   WN-   WN-
    WN-     WN-     WN-   Azer-   Azer-     WN-  WN- Kunjin-     WN-
Romania- Senegal- New York- baijan- baijan- Romania- Egypt-  Aust-   Nigeria
Virus strain   1996M    1993   1999H  1967  1970   1996H  1951  1960 (Wengler)
WN-Volgograd- 100 100 98.2 93.9   93.9   93.9 92.3 86.7 74.5
  1999-1 and WN-   96.6 94.6 95.2   92.5 85.0 78.2
  Volgograd-
  1999-11*
Romania-1996M 100 98.2 93.9   93.9   93.9 92.3 86.7 74.5
96.6 94.6   95.2 92.5 85.0 78.2
WN-Kenya-1998 98.2 93.9   93.9   93.9 92.3 86.7 74.5
  and WN-
  Senegal-1993
WN-New York- 95.8   95.8   95.8 94.5 87.3 75.8
  1999F and WN- 95.2   94.6 93.2 85.7 78.9
  New York-1999H
WN-Azer- 100 100 97.6 88.5 75.8
  baijan-1967   99.3 98.0 87.8 78.2
WN-Azerbaijan- 100 97.6 88.5 75.8
  1970 97.3 88.4 78.2
WN-Romania- 97.6 88.5 75.8
  1996H
WN-Egypt-1951 87.9 75.8
87.1 76.2
Kunjin-Aust-1960 75.1
72.8
WN-Nigeria
  (Wengler)
*First lines in a row = percentage identity of nucleotide sequence for E gene fragment; second lines in a row = percentage
identity of nucleotide sequence for NS5 gene fragment (if available). The strains with identical sequences of E and NS5
fragments are placed in the same row or column.131 Vol. 7, No. 1, January–February 2001 Emerging Infectious Diseases
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WN-Egypt-1951 strain and the Romanian human
isolate (Figure). The New York-1999 isolate
differed from the Volgograd isolates in 3 nt
positions and from the Azerbaijan isolates in 7 nt
positions. All 10 polymorphic sites in sequences
of Volgograd, New York, Azerbaijan, and
Figure. Phylogenetic trees based on nucleic sequence data of E-glycoprotein gene fragment of 165 bp. The trees
were constructed with the program CLUSTAL by using the neighbor joining method of Saitou and Nei with
bootstrapping. Tree is rooted by using Japanese encephalitis sequence as an outgroup. The designation of isolates
corresponds to that in publications (5,10), where details of isolate history are given. Alignments used for analysis
are available upon request from the authors.
aWN virus strains used in phylogenetic analysis. WN-Volgograd-1999-1 = human brain tissue from female patient, Volgograd,
Russia, GenBank accession # AF239988 (E gene fragment) and #AF239990 (NS5 gene fragment); WN-Kenya-1998 = strain
KN3829 isolated from Culex univittatus, # AF146082; WN-Senegal-1993 = strain SEN-ArD93548 isolated from Culex neavei,
# AF001570; WN-Romania-1996M = strain RO97-50 isolated from Culex pipiens pool, # AF260969; WN-New-York-1999F =
strain NY99-flamingo382-99 isolated from Bronx Zoo flamingo 1999, # AF196835; WN-New-York-1999H = strain HNY1999
isolated from total human brain RNA, # AF202541; WN-Azerbaijan-1967 = isolated from a bird, # AF241822 (NS5 gene
fragment); WN-Azerbaijan-1970 = strain A-72 isolated from a tick Ornitodorus coniceps, # AF241821 (NS5 gene fragment) and
# AF237564 (E gene fragment); WN-Romania-1996H = strain RO96-1030 isolated from human CSF, # AF130363; WN-Egypt-
1951 = strain Eg101, #AF260968; Kunjin-Aust-1960 = Kunjin virus MRM61C, # D00246; WN-Nigeria = West Nile virus, #
M12294 and #NC_001563.
Romania strains were in the third codon position,
producing silent mutations. WN-Volgograd-1
differed from WN-Egypt-1951 in 1 amino acid
(aa) (Leu vs. Trp), from Kunjin in 1 aa (Asn vs.
Ser) and from WN-Nigeria in 5 aa within the E
fragment of 55 aa.132 Emerging Infectious Diseases Vol. 7, No. 1, January–February 2001
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Although a few sequences of WN virus NS5
gene were available, the data confirmed that the
WN virus strains of lineage 1 were more close to
each other (the differences in 0-11 nt of 147) than
to Kunjin, and especially distant from WN-
Nigeria (Wengler) strain (Table). Again, all 10
polymorphic sites in sequences of lineage 1
strains corresponded to the silent mutations
only. WN-Volgograd-1 differed from Kunjin in 1
aa (Lys vs. Arg) and from WN-Nigeria in 3 aa (Arg
vs. Lys, Arg vs. Lys, and Ile vs. Val) but differed,
for example, from Saint Louis (AF013416) in 11
aa within the NS5 fragment of 48 aa. The
isolation of WN virus from one of our clinical
brain samples, Volgograd-1999-4, will make
complete genome sequencing and further viro-
logic investigations possible (11).
Conclusions
Our data, together with those of previous
publications, document several outbreaks of
emerging WN virus infection in regions where
this disease was not found or was rarely found.
(There were a few isolations of WN virus in
Romania and the former Soviet Union before
1996-99.) Some isolates demonstrate a high
degree of similarity (New York-1999 and Israel-
1998; Volgograd-1999, Romania-1996-mosquito
isolate, Kenya-1998, and Senegal-1993;
Azerbaijan-1967 and Romania-1996-human iso-
late). Moreover, the last three large outbreaks
were caused by genetically similar strains (WN-
Romania-1996, WN-New York-1999, and WN-
Volgograd-1999), indicating the wide circulation
and emergence of potentially epidemic strains of
WN virus. All three cities, Bucharest, New York,
and Volgograd, are located near large bodies of
water and on bird migration pathways and all
had unusually dry summers the year of the
outbreak (12). Some clinical characteristics of the
recent WN virus epidemics were unexpected,
such as the high rate of neurologic disorders and
death. These unusual characteristics may be due
to the expansion of new pathogenic WN virus
strain(s) or to the peculiarities of the human host
response.
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